Table 3 Comparisons of computed tomographic findings between subgroups defined based on symptoms and physical activity questionnaires.
Less symptomatic (CAT < 10) | Symptomatic (CAT ≥ 10) | |||
---|---|---|---|---|
LSA > 60 (n = 82) | LSA ≤ 60 (n = 11) | LSA > 60 (n = 73) | LSA ≤ 60 (n = 27) | |
In-LAV950%, % | 13.0 ± 11.6 | 8.8 ± 9.2 | 15.9 ± 12.3† | 23.5 ± 14.2*†‡ |
Ex-LAV856%, % | 42.0 ± 18.1 | 29.5 ± 14.8 | 46.0 ± 18.5 | 60.1 ± 11.7*†‡ |
SAD%, % | 26.9 ± 11.5 | 18.8 ± 10.0 | 28.4 ± 11.2 | 35.8 ± 11.0*†‡ |
WA%, % | 63.9 ± 3.6 | 63.2 ± 2.4 | 65.1 ± 3.6 | 63.9 ± 2.7 |
CLE, n (%) | 40 (49%) | 5 (45%) | 43 (59%) | 21 (78%) |
PSE, n (%) | 42 (51%) | 4 (36%) | 28 (38%) | 16 (59%) |
TLCCT, % predicted | 94.9 ± 14.0 | 86.8 ± 14.0 | 95.9 ± 14.1 | 93.7 ± 14.8 |
FRCCT, % predicted | 111.0 ± 25.8 | 88.6 ± 15.7 | 115.0 ± 30.0† | 125.0 ± 23.4† |
PM index, cm2 /m2 | 10.5 ± 2.4 | 9.1 ± 1.2 | 10.3 ± 3.0 | 8.4 ± 2.7*‡ |
SAT index, cm2 /m2 | 10.1 ± 3.9 | 10.6 ± 3.0 | 10.6 ± 4.6 | 6.7 ± 3.9*†‡ |
ESM index, cm2 /m2 | 12.0 ± 2.5 | 11.5 ± 2.1 | 12.1 ± 3.0 | 10.5 ± 2.5‡ |
BMD, HU | 159.2 ± 43.6 | 101.0 ± 36.7* | 147.0 ± 48.6† | 144.0 ± 49.7† |
Agatston score > 400, n (%) | 19 (23%) | 3 (27%) | 22 (30%) | 8 (30%) |